gastric carcinoma
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: 1. Non-esophagogastric junction stage I-III gastric cancer that meets the diagnostic criteria and is determined by imaging to have no tumor recurrence or metastasis; 2. Have completed gastric cancer resection and have no plans for adjuvant therapy or have completed adjuvant therapy; 3.ECOG score: 0-2 points; 4.18-75 years old gender not limited; 5. The expected survival period is =3 months; 6. Voluntarily join the study sign the informed consent form have good compliance and cooperate with the follow-up.
Exclusion criteria
Exclusion criteria: 1. Those with primary tumors in other parts; 2. Mentally ill patients 3. Patients with severe and uncontrolled organic lesions or infections such as decompensated heart lung and kidney failure who cannot tolerate chemotherapy; 4. Patients who have received clinical trial treatment of small molecule drugs within 28 days or clinical trial treatment of large molecule drugs within 3 months; 5. Patients who are known to be allergic or intolerant to the investigational drug.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| the DFS rate within 2 years after the operation; | — |
Secondary
| Measure | Time frame |
|---|---|
| The median time of OS;Symptom and quality of life evaluation;Tumor marker;Median time of DFS;Life function status;NLR; | — |
Countries
China
Contacts
Guang'anmen Hospital of Chinese Academy of traditional Chinese medicine